10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
24.88
+1.30 (5.51%)
Apr 14, 2026, 3:52 PM EDT - Market open
10x Genomics Stock Forecast
Stock Price Forecast
The 14 analysts that cover 10x Genomics stock have a consensus rating of "Hold" and an average price target of $17.61, which forecasts a -29.22% decrease in the stock price over the next year. The lowest target is $6.50 and the highest is $25.
Price Target: $17.61 (-29.22%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for 10x Genomics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 2 | 2 | 2 | 3 | 3 |
| Hold | 6 | 8 | 9 | 9 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 13 | 13 | 14 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $18 → $24 | Hold | Maintains | $18 → $24 | -3.54% | Apr 7, 2026 |
| William Blair | William Blair | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Mar 31, 2026 |
| Stifel | Stifel | Strong Buy Maintains $20 → $25 | Strong Buy | Maintains | $20 → $25 | +0.48% | Mar 2, 2026 |
| UBS | UBS | Hold Maintains $14 → $20 | Hold | Maintains | $14 → $20 | -19.61% | Feb 20, 2026 |
| Stifel | Stifel | Strong Buy Maintains $15 → $20 | Strong Buy | Maintains | $15 → $20 | -19.61% | Feb 13, 2026 |
Financial Forecast
Revenue This Year
619.77M
from 642.82M
Decreased by -3.59%
Revenue Next Year
665.19M
from 619.77M
Increased by 7.33%
EPS This Year
-0.98
from -0.35
EPS Next Year
-0.76
from -0.98
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 655.2M | 721.4M | |||
| Avg | 619.8M | 665.2M | |||
| Low | 596.1M | 622.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.9% | 16.4% | |||
| Avg | -3.6% | 7.3% | |||
| Low | -7.3% | 0.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.72 | -0.23 | |||
| Avg | -0.98 | -0.76 | |||
| Low | -1.20 | -0.99 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.